YS Biopharma Co (YS Biopharma Co) EV-to-Revenue : 2.96 (As of May. 16, 2024)

View and export this data going back to 2023. Start your Free Trial

What is YS Biopharma Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, YS Biopharma Co's enterprise value is $234.66 Mil. YS Biopharma Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $79.17 Mil. Therefore, YS Biopharma Co's EV-to-Revenue for today is 2.96.

The historical rank and industry rank for YS Biopharma Co's EV-to-Revenue or its related term are showing as below:

YS' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.53 Med: 0.98 Max: 12.01
Current: 3

During the past 3 years, the highest EV-to-Revenue of YS Biopharma Co was 12.01. The lowest was 0.53. And the median was 0.98.

YS's EV-to-Revenue is ranked better than
73.68% of 1041 companies
in the Biotechnology industry
Industry Median: 8.07 vs YS: 3.00

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-16), YS Biopharma Co's stock price is $0.9653. YS Biopharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.85. Therefore, YS Biopharma Co's PS Ratio for today is 1.13.

YS Biopharma Co EV-to-Revenue Historical Data

The historical data trend for YS Biopharma Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YS Biopharma Co EV-to-Revenue Chart

YS Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

EV-to-Revenue

1.68

YS Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EV-to-Revenue	Get a 7-Day Free Trial			-	-	-	1.68	-

Competitive Comparison of YS Biopharma Co's EV-to-Revenue

For the Biotechnology subindustry, YS Biopharma Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YS Biopharma Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, YS Biopharma Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where YS Biopharma Co's EV-to-Revenue falls into.

YS Biopharma Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

YS Biopharma Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	234.658	/	79.167
	=	2.96

YS Biopharma Co's current Enterprise Value is $234.66 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. YS Biopharma Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $79.17 Mil.

YS Biopharma Co (NAS:YS) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

YS Biopharma Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.9653	/	0.851
	=	1.13

YS Biopharma Co's share price for today is $0.9653.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2023 was $0.85.

YS Biopharma Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of YS Biopharma Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

YS Biopharma Co (YS Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » YS Biopharma Co Ltd (NAS:YS) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.